Identification of gefitinib off-targets using a structure-based systems biology approach; their validation with reverse docking and retrospective data mining | Scientific Reports
Frontiers | EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies | Oncology
JCM | Free Full-Text | Synergistic Action of Gefitinib and GSK41364A Simultaneously Loaded in Ratiometrically-Engineered Polymeric Nanoparticles for Glioblastoma Multiforme | HTML
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
Anti‐tumor activity of WK88‐1, a novel geldanamycin derivative, in gefitinib‐resistant non‐small cell lung cancers with Met amplification - Jang - 2014 - Cancer Science - Wiley Online Library
Mechanisms of acquired resistance to gefitinib/erlotinib in... | Download Scientific Diagram
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer | European Respiratory Society
Gefitinib - an overview | ScienceDirect Topics
Action mechanism of epidermal growth factor receptor-tyrosine kinase... | Download Scientific Diagram
Frontiers | Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study | Oncology
Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro - ScienceDirect
EGFR pathway and mechanism of action of osimertinib. Abbreviation:... | Download Scientific Diagram
Dacoplice® | Pfizer India | Mechanism of action
Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer | Oncotarget
Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors - International Journal of Radiation Oncology, Biology, Physics
Epithelial membrane protein-1 is a biomarker of gefitinib resistance | PNAS
Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway - ScienceDirect
Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer - touchONCOLOGY
EGFR pathway and mechanism of action of osimertinib. Abbreviation:... | Download Scientific Diagram
Mechanism of action of gefitinib. EGF = epidermal growth factor; EGFR =... | Download Scientific Diagram
Enoxaparin Sensitizes Human Non–Small-Cell Lung Carcinomas to Gefitinib by Inhibiting DOCK1 Expression, Vimentin Phosphorylation, and Akt Activation | Molecular Pharmacology
Mechanism of action of gefitinib. EGF = epidermal growth factor; EGFR =... | Download Scientific Diagram
Anti-EGFR Mechanism of Action: Antitumor Effect and Underlying Cause of Adverse Events
